Custom Recombinant Protein Production Services Market Size Is Anticipated To Reach US$ 8,403.0 Million at a CAGR of 11.4% By 2028

𝐂𝐮𝐬𝐭𝐨𝐦 𝐑𝐞𝐜𝐨𝐦𝐛𝐢𝐧𝐚𝐧𝐭 𝐏𝐫𝐨𝐭𝐞𝐢𝐧 𝐏𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧 𝐒𝐞𝐫𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐜𝐨𝐧𝐭𝐢𝐧𝐮𝐞𝐬 𝐭𝐨 𝐠𝐫𝐨𝐰 𝐚𝐬 𝐓𝐫𝐞𝐧𝐳𝐲𝐦𝐞 𝐆𝐦𝐛𝐇 𝐨𝐟𝐟𝐞𝐫𝐬 𝐫𝐞𝐜𝐨𝐦𝐛𝐢𝐧𝐚𝐧𝐭 𝐒𝐀𝐑𝐒-𝐂𝐨𝐕-𝟐 𝐒𝟏 𝐩𝐫𝐨𝐭𝐞𝐢𝐧 𝐭𝐨 𝐬𝐮𝐩𝐩𝐨𝐫𝐭 𝐜𝐨𝐫𝐨𝐧𝐚𝐯𝐢𝐫𝐮𝐬 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡

Protein production services are critical in the ongoing medical and biotechnology industries. It has been noted that there are thousands of proteins involved in the structure and function of living organisms and cells. In fact, these proteins play a vital role in the development of many of today's advanced medicines. Thus, it would be of great benefit if the company's protein products could be made more bio-available. Continuous research and development activities have led to key advancements in customer recombinant protein. Recombinant proteins are typically used in medical research for the treatment of major diseases including dwarfism, diabetes, congestive heart failure, myocardial infarction, cerebral apoplexy, and more. Key companies in the biotechnology industry are focused on R&D activities to expand their product portfolio. Recently, in February 2021, Sanofi and GSK initiated a new Phase 2 study of their adjuvanted recombinant protein-based COVID-19 vaccine candidate with 720 volunteers aged 18 years and above. Hence, such factors can stimulate growth of the custom recombinant protein production services market.

Apart from constant R&D, key industry players are laying significant emphasis on product launches. The primary focus is to expand their recombinant protein production services and capability. Recently, in June 2020, Lonza Company introduced GSv9 Media and Feeds, which provides a fully integrated solution mainly designed to optimize recombinant protein production. Thus, these factors can augment growth of the custom recombinant protein production services market in the near future.

𝐁𝐮𝐲 𝐍𝐨𝐰 𝐚𝐧𝐝 𝐆𝐞𝐭 𝐅𝐥𝐚𝐭 𝟑𝟎% 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭

𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐓𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐩𝐨𝐫𝐭 𝐓𝐨 𝐀𝐜𝐜𝐞𝐬𝐬 𝐅𝐮𝐥𝐥 𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 @ https://www.coherentmarketinsights.com/insight/buy-now/2737

𝐑𝐞𝐜𝐞𝐧𝐭𝐥𝐲, 𝐢𝐧 𝐌𝐚𝐫𝐜𝐡 𝟐𝟎𝟐𝟎, 𝐓𝐫𝐞𝐧𝐳𝐲𝐦𝐞 𝐆𝐦𝐛𝐇 𝐢𝐧𝐭𝐫𝐨𝐝𝐮𝐜𝐞𝐝 𝐫𝐞𝐜𝐨𝐦𝐛𝐢𝐧𝐚𝐧𝐭 𝐒𝐀𝐑𝐒-𝐂𝐨𝐕-𝟐 𝐒𝟏 𝐩𝐫𝐨𝐭𝐞𝐢𝐧 𝐭𝐨 𝐬𝐮𝐩𝐩𝐨𝐫𝐭 𝐜𝐨𝐫𝐨𝐧𝐚𝐯𝐢𝐫𝐮𝐬 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡.

Protein production by this means involves the utilization of existing proteins and also the conversion of these proteins to other forms, which can then be utilized in treating diseases. This type of protein production can produce products that could be used for various uses. As far as the regional footprint is concerned, developed regions including North America seem to be gaining significant traction in the custom recombinant protein production services market. This is typically due to the fact that research and development activities are on a rise in the said region along with new product launches. Recently, in December 2019, iBio Inc. launched the FastGlycaneering Development Service for engineering high-performance recombinant proteins.

Regardless of these advantageous factors, the adoption of recombinant protein remains limited. One of the key hurdles in the adoption of these services is high cost of the recombinant protein for a particular requirement. The price can range from US$ 3 to US$ 160 per amino acid. Thus, such factors can potentially impede growth of the custom recombinant protein production services market.

𝐓𝐨 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐋𝐚𝐭𝐞𝐬𝐭 𝐂𝐨𝐯𝐢𝐝𝟏𝟗 𝐈𝐦𝐩𝐚𝐜𝐭 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 @ https://www.coherentmarketinsights.com/insight/request-sample/2737

Detailed Segmentation:

⁃ 𝐂𝐮𝐬𝐭𝐨𝐦 𝐑𝐞𝐜𝐨𝐦𝐛𝐢𝐧𝐚𝐧𝐭 𝐏𝐫𝐨𝐭𝐞𝐢𝐧 𝐏𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧 𝐒𝐞𝐫𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭, 𝐁𝐲 𝐄𝐱𝐩𝐫𝐞𝐬𝐬𝐢𝐨𝐧 𝐒𝐲𝐬𝐭𝐞𝐦:

• Mammalian
• Bacteria
• Insect
• Yeast
• Others

⁃ 𝐂𝐮𝐬𝐭𝐨𝐦 𝐑𝐞𝐜𝐨𝐦𝐛𝐢𝐧𝐚𝐧𝐭 𝐏𝐫𝐨𝐭𝐞𝐢𝐧 𝐏𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧 𝐒𝐞𝐫𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭, 𝐁𝐲 𝐄𝐧𝐝 𝐔𝐬𝐞𝐫:

• Research Institutes
• Biotechnology and Pharmaceutical Companies
• Contract Research Organizations
• Others

⁃ 𝐂𝐮𝐬𝐭𝐨𝐦 𝐑𝐞𝐜𝐨𝐦𝐛𝐢𝐧𝐚𝐧𝐭 𝐏𝐫𝐨𝐭𝐞𝐢𝐧 𝐏𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧 𝐒𝐞𝐫𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭, 𝐁𝐲 𝐑𝐞𝐠𝐢𝐨𝐧:

• North America
• Latin America
• Europe
• Africa
• Asia Pacific
• Middle East

𝐓𝐨 𝐆𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 𝐇𝐞𝐫𝐞 @ https://www.coherentmarketinsights.com/insight/request-pdf/2737

Contact Us:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

About US:

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

This release was published on openPR.